Last 12 months
Inside the activity.
2 purchase rows · 24 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 9 |
| Dec 2025 | 0 | 4 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 10 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 2 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2025 Filed Mar 4, 2025 22:02 UTC |
SHUMWAY LOGANVP, Processing Operations
|
PurchaseCommon Shares | 7,500 | $4.10 | $30,750.00 |
DisclosureSEC source: 0000912282-25-000225 · form4.xml · nonDerivative · entry 1 SHUMWAY LOGAN · CIK 0001989978 · VP, Processing Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,676 Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:56 UTC |
ESTABROOKE IVYDirector
|
GrantCommon Shares | 18,859 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000123 · form4.xml · nonDerivative · entry 1 ESTABROOKE IVY · CIK 0001908813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,143 F1 · shares: Reflects grant of 40,284 RSUs which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:51 UTC |
HANSEN BRUCE DDirector
|
GrantCommon Shares | 18,859 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000120 · form4.xml · nonDerivative · entry 1 HANSEN BRUCE D · CIK 0001064614 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,239 F1 · shares: Reflects grant of 18,859 restricted stock units which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:47 UTC |
HIGGS DENNIS LYLEDirector
|
GrantCommon Shares | 18,859 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000118 · form4.xml · nonDerivative · entry 1 HIGGS DENNIS LYLE · CIK 0001134878 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 306,382 F1 · shares: Represents grant of 18,859 restricted stock units which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:26 UTC |
STIRZAKER MICHAELDirector
|
GrantCommon Shares | 18,859 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000107 · form4.xml · nonDerivative · entry 1 STIRZAKER MICHAEL · CIK 0002040273 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,533 F1 · shares: Represents grant of 18,859 restricted share units, which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:15 UTC |
DRERA SALEEMVP Radioisotopes, Radiological · Systems & IP
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 18,636 | $0.00 Strike: $6.11 | $0.00 |
DisclosureSEC source: 0000912282-25-000100 · form4.xml · derivative · entry 2 DRERA SALEEM · CIK 0002035000 · VP Radioisotopes, Radiological · Systems & IP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,636 Underlying: Common Shares · 18,636 shares Expires 2030-01-29 F2 · derivative.exercise_date: Reflects grant of 18,636 options having a strike price at a 10% premium of the grant price of $5.56, which vest as follows: 50% on 1/29/2026 and 50% on 1/29/2027. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:15 UTC |
DRERA SALEEMVP Radioisotopes, Radiological · Systems & IP
|
GrantCommon Shares | 19,036 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000100 · form4.xml · nonDerivative · entry 1 DRERA SALEEM · CIK 0002035000 · VP Radioisotopes, Radiological · Systems & IP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,069 F1 · shares: Reflects grant of 19,036 RSUs which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:20 UTC |
CARSTENS TIMOTHY JAMESEVP, Heavy Mineral Sands Ops
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 124,386 | $0.00 Strike: $6.11 | $0.00 |
DisclosureSEC source: 0000912282-25-000103 · form4.xml · derivative · entry 3 CARSTENS TIMOTHY JAMES · CIK 0002040047 · EVP, Heavy Mineral Sands Ops 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,386 Underlying: Common Shares · 124,386 shares Expires 2030-01-29 F3 · derivative.exercise_date: Reflects a grant of 50,350 options having a strike price at a 10% premium of the grant price of $5.56, which vest as follows: 50% on 1/29/2026 and 50% on 1/29/2027. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:20 UTC |
CARSTENS TIMOTHY JAMESEVP, Heavy Mineral Sands Ops
|
GrantCommon Shares | 102,673 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000103 · form4.xml · nonDerivative · entry 1 CARSTENS TIMOTHY JAMES · CIK 0002040047 · EVP, Heavy Mineral Sands Ops 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 727,641 F1 · shares: Represents grant of 102,673 RSUs which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:30 UTC |
LONGENECKER NATHANSr VP and General Counsel
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 61,303 | $0.00 Strike: $6.11 | $0.00 |
DisclosureSEC source: 0000912282-25-000109 · form4.xml · derivative · entry 2 LONGENECKER NATHAN · CIK 0002033958 · Sr VP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,303 Underlying: Common Shares · 61,303 shares Expires 2030-01-29 F2 · derivative.exercise_date: Reflects grant of 61,303 options having a strike price at a 10% premium of the grant price of $5.56, which vest as follows: 50% on 1/29/2026 and 50% on 1/29/2027. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:30 UTC |
LONGENECKER NATHANSr VP and General Counsel
|
GrantCommon Shares | 62,620 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000109 · form4.xml · nonDerivative · entry 1 LONGENECKER NATHAN · CIK 0002033958 · Sr VP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,916 F1 · shares: Represents grant of 62,620 restricted stock units which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:22 UTC |
Bennett Nathan ReedCAO & Interim CFO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 25,808 | $0.00 Strike: $6.11 | $0.00 |
DisclosureSEC source: 0000912282-25-000104 · form4.xml · derivative · entry 2 Bennett Nathan Reed · CIK 0002006665 · CAO & Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,808 Underlying: Common Shares · 25,808 shares Expires 2030-01-29 F2 · derivative.exercise_date: Reflects grant of 25,808 options having a strike price at a 10% premium of the grant price of $5.56, which vest as follows: 50% on 1/29/2026 and 50% on 1/29/2027. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:22 UTC |
Bennett Nathan ReedCAO & Interim CFO
|
GrantCommon Shares | 26,362 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000104 · form4.xml · nonDerivative · entry 1 Bennett Nathan Reed · CIK 0002006665 · CAO & Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,089 F1 · shares: Reflects grant of 26,362 restricted stock units which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:49 UTC |
HERRERA JAQUELINEDirector
|
GrantCommon Shares | 18,859 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000119 · form4.xml · nonDerivative · entry 1 HERRERA JAQUELINE · CIK 0001932289 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,857 F1 · shares: Represents grant of 18,859 restricted stock units which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:44 UTC |
Kirkwood Robert W.Director
|
GrantCommon Shares | 20,499 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000117 · form4.xml · nonDerivative · entry 1 Kirkwood Robert W. · CIK 0001706990 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 462,481 F1 · shares: Represents grant of 20,499 restricted stock units which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:41 UTC |
Bovaird J. BirksDirector
|
GrantCommon Shares | 27,587 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000115 · form4.xml · nonDerivative · entry 1 Bovaird J. Birks · CIK 0001662181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,791 F1 · shares: Reflects grant of 27,587 restricted stock units which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:43 UTC |
Morrison Alex GDirector
|
GrantCommon Shares | 22,958 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000116 · form4.xml · nonDerivative · entry 1 Morrison Alex G · CIK 0001562603 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,486 F1 · shares: Reflects grant of 22,958 restricted stock units which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:53 UTC |
Filas Barbara AppelinDirector
|
GrantCommon Shares | 20,499 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000121 · form4.xml · nonDerivative · entry 1 Filas Barbara Appelin · CIK 0001455291 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,159 F1 · shares: Reflects grant of 20,499 RSUs which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:54 UTC |
Eshleman Benjamin IIIDirector
|
GrantCommon Shares | 20,499 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000122 · form4.xml · nonDerivative · entry 1 Eshleman Benjamin III · CIK 0001707162 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,141 F1 · shares: Reflects grant of 20,499 RSUs which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:39 UTC |
BAKKEN SCOTTVP, Regulatory Affairs
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 22,334 | $0.00 Strike: $6.11 | $0.00 |
DisclosureSEC source: 0000912282-25-000114 · form4.xml · derivative · entry 2 BAKKEN SCOTT · CIK 0001823094 · VP, Regulatory Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,334 Underlying: Common Shares · 22,334 shares Expires 2030-01-29 F2 · derivative.exercise_date: Reflects grant of 22,334 options having a strike price at a 10% premium of the grant price of $5.56, which vest as follows: 50% on 1/29/2026 and 50% on 1/29/2027. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:39 UTC |
BAKKEN SCOTTVP, Regulatory Affairs
|
GrantCommon Shares | 22,814 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000114 · form4.xml · nonDerivative · entry 1 BAKKEN SCOTT · CIK 0001823094 · VP, Regulatory Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,446 F1 · shares: Reflects grant of 22,814 restricted stock units which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:36 UTC |
NAZARENUS DEE ANNVP HR & Administration
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 20,451 | $0.00 Strike: $6.11 | $0.00 |
DisclosureSEC source: 0000912282-25-000113 · form4.xml · derivative · entry 2 NAZARENUS DEE ANN · CIK 0001822944 · VP HR & Administration 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,451 Underlying: Common Shares · 20,451 shares Expires 2030-01-29 F2 · derivative.exercise_date: Reflects grant of 20,451 options having a strike price at a 10% premium of the grant price of $5.56, which vest as follows: 50% on 1/29/2026 and 50% on 1/29/2027. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:36 UTC |
NAZARENUS DEE ANNVP HR & Administration
|
GrantCommon Shares | 20,890 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000113 · form4.xml · nonDerivative · entry 1 NAZARENUS DEE ANN · CIK 0001822944 · VP HR & Administration 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,660 F1 · shares: Represents grant of 20,890 restricted stock units which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:28 UTC |
SHUMWAY LOGANVP, Processing Operations
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 21,105 | $0.00 Strike: $6.11 | $0.00 |
DisclosureSEC source: 0000912282-25-000108 · form4.xml · derivative · entry 2 SHUMWAY LOGAN · CIK 0001989978 · VP, Processing Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,105 Underlying: Common Shares · 21,105 shares Expires 2030-01-29 F2 · derivative.exercise_date: Reflects grant of 21,105 options having a strike price at a 10% premium of the grant price of $5.56, which vest as follows: 50% on 1/29/2026 and 50% on 1/29/2027. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:28 UTC |
SHUMWAY LOGANVP, Processing Operations
|
GrantCommon Shares | 21,559 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000108 · form4.xml · nonDerivative · entry 1 SHUMWAY LOGAN · CIK 0001989978 · VP, Processing Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,176 F1 · shares: Represents grant of 21,559 restricted stock units which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:24 UTC |
Moore CurtisSVP Marketing/Corp Development
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,350 | $0.00 Strike: $6.11 | $0.00 |
DisclosureSEC source: 0000912282-25-000106 · form4.xml · derivative · entry 2 Moore Curtis · CIK 0001662070 · SVP Marketing/Corp Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,350 Underlying: Common Shares · 50,350 shares Expires 2030-01-29 F2 · derivative.exercise_date: Reflects a grant of 50,350 options having a strike price at a 10% premium of the grant price of $5.56, which vest as follows: 50% on 1/29/2026 and 50% on 1/29/2027. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:24 UTC |
Moore CurtisSVP Marketing/Corp Development
|
GrantCommon Shares | 51,432 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000106 · form4.xml · nonDerivative · entry 1 Moore Curtis · CIK 0001662070 · SVP Marketing/Corp Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,193 F1 · shares: Represents grant of 51,432 restricted stock units which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:23 UTC |
Frydenlund David C.EVP & Chief Legal Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 97,231 | $0.00 Strike: $6.11 | $0.00 |
DisclosureSEC source: 0000912282-25-000105 · form4.xml · derivative · entry 2 Frydenlund David C. · CIK 0001662034 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,231 Underlying: Common Shares · 97,231 shares Expires 2030-01-29 F2 · derivative.exercise_date: Reflects grant of 97,231 options having a strike price at a 10% premium of the grant price of $5.56, which vest as follow: 50% on 1/29/2026 and 50% on 1/29/2027. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:23 UTC |
Frydenlund David C.EVP & Chief Legal Officer
|
GrantCommon Shares | 99,319 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000105 · form4.xml · nonDerivative · entry 1 Frydenlund David C. · CIK 0001662034 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 630,648 F1 · shares: Reflects grant of 99,319 RSUs which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:18 UTC |
BONIFAS BERNARDVP, ISR Operations
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 20,680 | $0.00 Strike: $6.11 | $0.00 |
DisclosureSEC source: 0000912282-25-000102 · form4.xml · derivative · entry 2 BONIFAS BERNARD · CIK 0001989558 · VP, ISR Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,680 Underlying: Common Shares · 20,680 shares Expires 2030-01-29 F2 · derivative.exercise_date: Reflects grant of 20,680 options having a strike price at a 10% premium of the grant price of $5.56, which vest as follows: 50% on 1/29/2026 and 50% on 1/29/2027. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:18 UTC |
BONIFAS BERNARDVP, ISR Operations
|
GrantCommon Shares | 21,125 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000102 · form4.xml · nonDerivative · entry 1 BONIFAS BERNARD · CIK 0001989558 · VP, ISR Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,192 F1 · shares: Reflects grant of 21,125 restricted stock units which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:15 UTC |
Chalmers MarkDirector · President & CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 162,550 | $0.00 Strike: $6.11 | $0.00 |
DisclosureSEC source: 0000912282-25-000101 · form4.xml · derivative · entry 2 Chalmers Mark · CIK 0001678867 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,550 Underlying: Common Shares · 162,550 shares Expires 2030-01-29 F2 · derivative.exercise_date: Reflects grant of 162,550 options having a strike price at a 10% premium of the grant price of $5.56, which vest as follows: 50% on 1/29/2026 and 50% on 1/29/2027. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:15 UTC |
Chalmers MarkDirector · President & CEO
|
GrantCommon Shares | 166,042 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000101 · form4.xml · nonDerivative · entry 1 Chalmers Mark · CIK 0001678867 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,061,343 F1 · shares: Reflects grant of 166,042 RSUs which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:13 UTC |
KAPOSTASY DANIELVP, Technical Services
|
GrantEmployee Stock Option (Right to · Derivative | 20,598 | $0.00 Strike: $6.11 | $0.00 |
DisclosureSEC source: 0000912282-25-000099 · form4.xml · derivative · entry 2 KAPOSTASY DANIEL · CIK 0001989355 · VP, Technical Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,598 Underlying: Common Shares · 20,598 shares Expires 2030-01-29 F2 · derivative.exercise_date: Reflects grant of 20,598 options having a strike price at a 10% premium of the grant price of $6.11, which vest as follows: 50% on 1/29/2026 and 50% on 1/29/2027. Read SEC document |
| January 29, 2025 Filed Feb 1, 2025 02:13 UTC |
KAPOSTASY DANIELVP, Technical Services
|
GrantCommon Shares | 21,040 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000099 · form4.xml · nonDerivative · entry 1 KAPOSTASY DANIEL · CIK 0001989355 · VP, Technical Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,568 F1 · shares: Represents grant of 21,040 restricted stock units which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 29, 2025 Filed Mar 7, 2025 19:41 UTC |
BENNETHUM DEBRAVP Critical Minerals/Strategic · Supply Chain
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 8,936 | $0.00 Strike: $6.11 | $0.00 |
DisclosureSEC source: 0000912282-25-000259 · form4.xml · derivative · entry 3 BENNETHUM DEBRA · CIK 0002055600 · VP Critical Minerals/Strategic · Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,936 Underlying: Common Shares · 8,936 shares Expires 2030-01-29 F2 · derivative.exercise_date: Reflects grant of 8,936 options having a strike price at a 10% premium of the grant price of $5.56, which vest as follows: 50% on 1/29/2026 and 50% on 1/29/2027. Read SEC document |
| January 29, 2025 Filed Mar 7, 2025 19:41 UTC |
BENNETHUM DEBRAVP Critical Minerals/Strategic · Supply Chain
|
GrantCommon Shares | 7,376 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-000259 · form4.xml · nonDerivative · entry 1 BENNETHUM DEBRA · CIK 0002055600 · VP Critical Minerals/Strategic · Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,349 F1 · shares: Reflects grant of 7,376 restricted stock units which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 29, 2025 Filed Dec 1, 2025 17:53 UTC Amendment |
Bennett Nathan ReedCAO & Interim CFO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 25,808 | $0.00 Strike: $6.11 | $0.00 |
DisclosureSEC source: 0000912282-25-001347 · form4a.xml · derivative · entry 2 Bennett Nathan Reed · CIK 0002006665 · CAO & Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,808 Underlying: Common Shares · 25,808 shares Expires 2030-01-29 F2 · derivative.exercise_date: Reflects grant of 25,808 options having a strike price at a 10% premium of the grant price of $5.56, which vest as follows: 50% on 1/29/2026 and 50% on 1/29/2027. Read SEC document |
| January 29, 2025 Filed Dec 1, 2025 17:53 UTC Amendment |
Bennett Nathan ReedCAO & Interim CFO
|
GrantCommon Shares | 26,362 | $0.00 | $0.00 |
DisclosureSEC source: 0000912282-25-001347 · form4a.xml · nonDerivative · entry 1 Bennett Nathan Reed · CIK 0002006665 · CAO & Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,089 F1 · shares: Reflects grant of 26,362 restricted stock units which vest as follows: 50% on 1/27/2026; 25% on 1/27/2027; and 25% on 1/27/2028. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 21:17 UTC |
HIGGS DENNIS LYLEDirector
|
Tax withholdingCommon Shares | 3,899 | $5.17 | $20,157.83 |
DisclosureSEC source: 0000912282-25-000079 · form4.xml · nonDerivative · entry 1 HIGGS DENNIS LYLE · CIK 0001134878 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,523 Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 21:11 UTC |
DRERA SALEEMVP Radioisotopes, Radiological · Systems & IP
|
Tax withholdingCommon Shares | 1,373 | $5.17 | $7,098.41 |
DisclosureSEC source: 0000912282-25-000075 · form4.xml · nonDerivative · entry 1 DRERA SALEEM · CIK 0002035000 · VP Radioisotopes, Radiological · Systems & IP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,033 Read SEC document |
| January 27, 2025 Filed Jan 30, 2025 02:23 UTC |
LONGENECKER NATHANSr VP and General Counsel
|
Tax withholdingCommon Shares | 6,544 | $5.17 | $33,832.48 |
DisclosureSEC source: 0000912282-25-000083 · form4.xml · nonDerivative · entry 1 LONGENECKER NATHAN · CIK 0002033958 · Sr VP and General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,296 Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 20:59 UTC |
Bennett Nathan ReedCAO & Interim CFO
|
Tax withholdingCommon Shares | 4,285 | $5.17 | $22,153.45 |
DisclosureSEC source: 0000912282-25-000067 · form4.xml · nonDerivative · entry 1 Bennett Nathan Reed · CIK 0002006665 · CAO & Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,727 Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 21:04 UTC |
Bovaird J. BirksDirector
|
Tax withholdingCommon Shares | 6,176 | $5.17 | $31,929.92 |
DisclosureSEC source: 0000912282-25-000071 · form4.xml · nonDerivative · entry 1 Bovaird J. Birks · CIK 0001662181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,204 Read SEC document |
| January 27, 2025 Filed Jan 30, 2025 02:33 UTC |
SHUMWAY LOGANVP, Processing Operations
|
Tax withholdingCommon Shares | 4,998 | $5.17 | $25,839.66 |
DisclosureSEC source: 0000912282-25-000089 · form4.xml · nonDerivative · entry 1 SHUMWAY LOGAN · CIK 0001989978 · VP, Processing Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,617 Read SEC document |
| January 27, 2025 Filed Jan 30, 2025 02:29 UTC |
NAZARENUS DEE ANNVP HR & Administration
|
Tax withholdingCommon Shares | 6,034 | $5.17 | $31,195.78 |
DisclosureSEC source: 0000912282-25-000087 · form4.xml · nonDerivative · entry 1 NAZARENUS DEE ANN · CIK 0001822944 · VP HR & Administration 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,770 Read SEC document |
| January 27, 2025 Filed Jan 30, 2025 02:26 UTC |
Moore CurtisSVP Marketing/Corp Development
|
Tax withholdingCommon Shares | 11,541 | $5.17 | $59,666.97 |
DisclosureSEC source: 0000912282-25-000085 · form4.xml · nonDerivative · entry 1 Moore Curtis · CIK 0001662070 · SVP Marketing/Corp Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,761 Read SEC document |
| January 27, 2025 Filed Jan 30, 2025 02:14 UTC |
Frydenlund David C.Executive VP, CLO & Secretary
|
Tax withholdingCommon Shares | 26,172 | $5.17 | $135,309.24 |
DisclosureSEC source: 0000912282-25-000077 · form4.xml · nonDerivative · entry 1 Frydenlund David C. · CIK 0001662034 · Executive VP, CLO & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 531,329 Read SEC document |
| January 27, 2025 Filed Jan 30, 2025 02:20 UTC |
KAPOSTASY DANIELVP, Technical Services
|
Tax withholdingCommon Shares | 4,889 | $5.17 | $25,276.13 |
DisclosureSEC source: 0000912282-25-000081 · form4.xml · nonDerivative · entry 1 KAPOSTASY DANIEL · CIK 0001989355 · VP, Technical Services 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,528 Read SEC document |
| January 27, 2025 Filed Jan 30, 2025 02:07 UTC |
Chalmers MarkDirector · President & CEO
|
Tax withholdingCommon Shares | 45,372 | $5.17 | $234,573.24 |
DisclosureSEC source: 0000912282-25-000073 · form4.xml · nonDerivative · entry 1 Chalmers Mark · CIK 0001678867 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 895,301 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.